483 Anna Kostera-Pruszczyk, MD, PhD Jul 2018

483 Anna Kostera-Pruszczyk, MD, PhD Jul 2018

Sunitha Rajaram FDA$119.00 - Available Now

FDA investigators audited the Anna Kostera-Pruszczyk, MD, PhD - Warsaw, Poland facility and issued inspectional observations (via FDA 483) on 13 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jul 2018
  • Location: Warsaw, Poland
  • FEI: 3014450811
Add To Cart